
Introducing micSTAT AST
Fast and Accurate Is Good
Fast, Accurate With Simple Sample Prep Is Better
RDx micSTAT AST…Quantitative MIC Values in Approximately 4 Hours* Direct-Out-Of-Positive Blood Culture With A Sample Prep Designed For Today’s 21st Century Micro Lab. No Centrifugations. No Filtrations. Just Dilute and Go.
Our mission
Renascent Diagnostics
Speed. Accuracy. Efficiency.
Renascent Dx is bringing the first automated digital microbiology platform to market to provide test results faster for patients and ultimately address the worldwide issue of antibiotic resistance that is affecting every area of clinical medical practice. At Renascent Dx we believe accurate results delivered faster improves both patient care and our general health community.

Digital Microbiology Applications
RDx’s MODe (Multi-Parameter Orthogonal Detection) platform offers a suite of assays to aid your laboratory, your physicians, and ultimately your patients.
micSTAT AST
RDx’s comprehensive antibiotic susceptibility test offering both MIC values and Categorical Designation in approximately 4 hours, either directly from positive blood culture or an isolate, with a sample prep workflow Even easier than current methods. A multitude of panel offerings will be available for both Gram negative and gram positive mono-pathogenic samples.
uSTAT
RDx’s UTI screening assay providing enumeration of both viable bacteria and white blood cells directly from urine in 6 minutes.
empiriSTAT UTI
A comprehensive UTI screening assay combining uSTAT with antibiotic profiling of the most common oral antibiotics used to treat UTI.
Renascent’s comprehensive assay for assessing urine specimens for suspicion of urinary tract infection aims to transform UTI testing. Providing enumerative values for WBCs, viable bacteria, and standardized antibiotic profiling in under 3 hours directly out of the specimen, Renascent’s empiriSTAT-UTI test is fast enough to ensure appropriate therapy early in the disease course.
* All tests are under development and not currently FDA approved

Our Science
Utilizing an ultra-sensitive, optical platform called MODe and coupled to proprietary chemistry RDx is able to
assess a multitude of parameters at an incredibly high rate to identify not just bacteria present in a complex sample
but viable bacteria directly out of a specimen without the need for lengthy overnight cultures. With the addition of a short
incubation RDx’s technology is able to determine the effect of a panel of antibiotics with high accuracy compared to broth microdilution and Kirby-Bauer methodologies in 4 hours.
Our Science Applied
Renascent Diagnostics is utilizing an incredibly sensitive and accurate multi-parameter platform to execute our quantitative, digital microbiology assays. With unmatched pre-analytical processing the system allows for “load-n-go” functionality, ensuring automated, standardized, and accurate assay execution.
Robust, validated science is at the core of Renascent Diagnostics technology. With the new demands of 21st century pathology labs in mind, the Renascent Diagnostics digital microbiology assays aim to redefine modern microbiology.
Renascent Diagnostics has developed proprietary chemistry for its quantitative assay that optimizes the identification of viable bacterial cells in urine specimens within minutes. This optimization has shown very high correlation to CFU enumeration after overnight culture. This differentiation between viable and non-viable bacterial cells is the key to accurate clinical diagnosis of UTI and determining growth inhibition for our AST tests.
Renascent Diagnostics has spent over 7 years optimizing both multi-parameter phenotypic strategies for direct assessment of bacteria in a multitude of complex matrices as well as internal QC algorithms that ensure assay integrity for each interrogation by the MODe platform. Additionally, the empiriSTAT-UTI algorithms allow for rapid profiling of antibiotic effects on the bacterial population allowing for patients to initiate appropriate therapy from the start.
Renascent diagnostics
Our Team
Renascent Diagnostics is building out its world-class team focused on commercializing its diagnostic platform with members embodying expertise in Quality Management, IVD Manufacturing, Clinical Development, and Regulatory submissions. Additionally, RDI is establishing a team of established experts in clinical microbiology, infectious disease, and clinical care to represent its Medical Advisory Board.
Antibiotic Resistance Resources and References

Why We Need to Act
Get in Touch
Renascent Diagnostics
If you’d like to learn more about our science, the clinical benefits of rapid detection of UTI, or our business plans please feel free to fill out the information form and we will be in touch.